EL DORADO HILLS, Calif.--(BUSINESS WIRE)--July 25, 2005--PhereSys(TM) Therapeutics Corporation (“PhereSys”) announced today that it has entered into a comprehensive consulting services agreement with Advanced Cell & Gene Therapy LLC (“ACGT”), Scott R. Burger, MD, Principal. Advanced Cell & Gene Therapy, LLC, located in Chapel Hill, North Carolina, is a consulting firm with extensive expertise in the fields of cell, gene and tissue therapies. The firm specifically provides guidance in development, GMP/GTP manufacturing and regulatory compliance, as well as scientific and technical strategic analysis of business opportunities in cell, gene and tissue therapies to biotechnology companies, clinical laboratories and biotechnology investors.
